NIH-funded research NIH-funded research

TRANSCEND: Translational science to improve North Dakota health

Official title: Translational Science Engaging North Dakota (TRANSCEND)

Funded at University of North Dakota · NIH-11392895 · Data updated 2026-11-12

A program to build and speed patient-centered translational research in North Dakota, focusing on the health problems most common in the state including neurodegenerative diseases and cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of North Dakota
NIH-funded
Lab location1 site (Grand Forks, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$2,146,647
NIH project number5P20GM155890-03
Project IDNIH-11392895 on NIH RePORTER

Who could benefit from this research

Could help

Patients in North Dakota with Alzheimer’s disease/dementia, Parkinson’s disease, colorectal cancer, or related conditions who might benefit from future translational research opportunities.

Less likely to help

Individuals not currently diagnosed with ND-specific health problems or who are not engaged in translational research activities may not directly benefit.

What this research studies

TRANSCEND is a translational research development program based in North Dakota that aims to boost collaboration between universities and clinics. It provides training, resources, and streamlined processes to move research ideas from the lab to patient care. The initiative targets diseases prevalent in ND, such as Alzheimer’s-related conditions and colorectal cancer, with attention to environmental factors that could influence health. By strengthening research infrastructure and support, it seeks to yield practical health improvements for North Dakotans.

Why it matters

Potential benefit: It could speed new diagnostics, treatments, or care strategies tailored to ND populations.

How similar studies have gone: Previous translational programs have shown that dedicated infrastructure and training can accelerate bringing research advances to patients.

Where this research is happening

  • University of North Dakota
    Grand Forks, United States
    Active

Researchers

  • Principal investigator: Schwartz, Gary G — University of North Dakota
  • Study coordinator: Schwartz, Gary G

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.